Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ADMA holding history

Adma Biologics, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ADMA overviewAll 13F holders of ADMAFull Q2 2026 holdings

Shares (Q2 2026)
1,173,033
Value
$9.82M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of ADMA by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20261,173,033$9.82M<0.1%−977,243−45.4%ReducedHolders
Q1 20262,150,276$19.4M<0.1%−2,419,067−52.9%ReducedHolders
Q4 20254,569,343$83.3M<0.1%+2,581,670+129.9%AddedHolders
Q3 20251,987,673$29.1M<0.1%−433,950−17.9%ReducedHolders
Q2 20252,421,623$44.1M<0.1%−395,191−14.0%ReducedHolders
Q1 20252,816,814$55.9M<0.1%+1,812,882+180.6%AddedHolders
Q4 20241,003,932$17.2M<0.1%+586,227+140.3%AddedHolders
Q3 2024417,705$8.35M<0.1%+43,768+11.7%AddedHolders
Q2 2024373,937$4.18M<0.1%−191,494−33.9%ReducedHolders
Q1 2024565,431$3.73M<0.1%+67,132+13.5%AddedHolders
Q4 2023498,299$2.25M<0.1%+270,160+118.4%AddedHolders
Q3 2023228,139$816.7K<0.1%−55,807−19.7%ReducedHolders
Q2 2023283,946$1.05M<0.1%−100,104−26.1%ReducedHolders
Q1 2023384,050$1.27M<0.1%−158,458−29.2%ReducedHolders
Q4 2022542,508$2.10M<0.1%+479,078+755.3%AddedHolders
Q3 202263,430$154.0K<0.1%+63,430NewHolders
Q2 20220$00.0%−11,395−100.0%Sold outHolders
Q1 202211,395$21.0K<0.1%+11,395NewHolders
Q4 20210$00.0%−18,435−100.0%Sold outHolders
Q3 202118,435$21.0K<0.1%+13,460+270.6%AddedHolders
Q2 20214,975$8.00K<0.1%−15,438−75.6%ReducedHolders
Q1 202120,413$36.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.